More Investing
View Older Stories View Newer Stories-
Catalent reports Q1 loss, misses market expectations
-
Marqeta stock plunges 30% on weak guidance, slowing growth
-
Hims&Hers Health Q3 earnings beat estimates, raises guidance
-
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.65%
-
Hyperscalers' massive 2025 capex hike for AI means big wins for NVIDIA
-
Abercrombie shares rally as Citi adds 'Positive Catalyst Watch'
-
Nvidia said to be routing orders away from Super Micro amid accounting woes
-
Bernstein downgrades Reckitt; litigation rollercoaster continues
-
Fiverr shares drop as BTIG cuts rating, removes from Top Pick list
-
ESSA Pharma downgraded by Oppenheimer, Piper Sandler after drug setback in trials
-
Peloton double-upgraded at BofA, 'many miles more of EBITDA growth likely'
-
Zoetis lifts full-year guidance amid strength at companion animal unit
-
DigitalOcean shares slump as Q4 earnings guidance falls short
-
Roblox shares jump as Morgan Stanley upgrades stock, raises PT to $65
-
NVIDIA to replace Intel in Dow Jones Industrial Average
-
Berkshire EPS misses estimates as insurance losses, mixed results weigh on Q3
-
Nvidia asked SK Hynix to speed up HBM4 chip production amid soaring AI demand
-
STMicroelectronics shares down as Morgan Stanley downgrades to "underweight"
-
Earnings could trigger Charter short squeeze - S3 Partners
-
Wall Street Analysts Downgrade Estee Lauder
-
Can NVIDIA's stock stay out of the SMCI fire?
-
Globalstar stock rockets 40% on expanded satellite service deal with Apple
-
Exxon Mobil reports above-consensus Q3 earnings but revenue misses estimates
-
Boeing shares higher as striking union endorses 38% pay bump
-
Reckitt, Abbott surge after winning an NEC case
-
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.90%
-
Intel shares surge on better-than-feared results, outlook
-
Amazon's Q3 earnings report beats expectations; shares gain
-
Wingstop lifted to Buy at BTIG, 'multiple levers remain'
-
Bernstein analysts lower rating of Arm Holdings, calling valuation "too steep"
-
Biogen down as Morgan Stanley cuts rating on sluggish Alzheimer’s drug launch
-
Deutsche Bank cuts Kraft Heinz rating following Q3 results
-
Buy Dell stock on SMCI's auditor woes - analyst
-
BNP Paribas shares sink as quarterly returns underwhelm investors
-
Kellanova beats third-quarter expectations amid strong organic sales growth
-
Mastercard beats expectations, shares rise
-
Rosenblatt suspends SMCI rating amid 'financial uncertainty'; shares fall again
-
TotalEnergies edges lower as quarterly profit hits 3-year low
-
Norwegian Cruise Line tops Q3 expectations, raises earnings guidance
-
Bristol-Myers hikes annual earnings guidance as Q3 exceeds expectations; shares up
-
Merck earnings top estimates amid solid demand for Keytruda cancer drug
-
Uber shares drop despite Q3 earnings, revenue beat
-
Peloton names Peter Stern as new CEO
-
Estee Lauder stock plunges, withdraws full-year outlook on China uncertainty
-
Estee Lauder stock plunges, withdraws full-year outlook on China uncertainty
-
Mobileye shares jump despite Q3 earnings, revenue miss
-
Stellantis third-quarter revenue beats estimates despite slipping by 27%
-
eBay stock tumbles on weak holiday quarter outlook
-
Coinbase Q3 earnings fall well short of estimates as trading volumes sag
-
Root shares soar 45% as insurer turns profitable in Q3
